Specific syndecan-1 domains regulate mesenchymal tumor cell adhesion, motility and migration

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Zong, Fang ^a   Fthenou, Eleni ^b   Mundt, Filip ^a   Szatmári, Tünde ^a   Kovalszky, Ilona ^c   Szilák, László ^d   Brodin, David ^a   Tzanakakis, George ^b   Hjerpe, Anders ^a   Dobra, Katalin ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF CRETE   (Greece)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d UNIVERSITY OF WEST HUNGARY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEOGLYCAN; SYNDECAN 1;

ARTICLE; BIOASSAY; CARBOHYDRATE TRANSPORT; CELL ADHESION; CELL FUNCTION; CELL MOTILITY; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MESENCHYME CELL; MICROARRAY ANALYSIS; MIGRATION INHIBITION; NUCLEAR LOCALIZATION SIGNAL; OLIGOMERIZATION; PROTEIN DOMAIN; PROTEIN FUNCTION; REGULATORY MECHANISM; STRUCTURE ACTIVITY RELATION; TUMOR CELL; TUMOR GROWTH; WOUND HEALING; AMINO ACID SEQUENCE; CELL MOTION; CELL NUCLEUS; CHEMISTRY; CHEMOTAXIS; FLOW CYTOMETRY; GENE DELETION; GENETICS; MESODERM; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PROTEIN MOTIF; PROTEIN TERTIARY STRUCTURE; PROTEIN TRANSPORT; TUMOR CELL LINE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL NUCLEUS; CHEMOTAXIS; FLOW CYTOMETRY; HUMANS; MESODERM; MOLECULAR SEQUENCE DATA; NUCLEAR LOCALIZATION SIGNALS; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; SEQUENCE DELETION; STRUCTURE-ACTIVITY RELATIONSHIP; SYNDECAN-1;

EID: 79959555754     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014816     Document Type: Article

References (56)

1. Webb DJ, Parsons JT, Horwitz AF, (2002) Adhesion assembly, disassembly and turnover in migrating cells - over and over and over again. Nat Cell Biol 4: E97-100.
2. Couchman JR, (2003) Syndecans: proteoglycan regulators of cell-surface microdomains? Nat Rev Mol Cell Biol 4: 926-937.
3. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, et al. (1999) Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68: 729-777.
4. Okina E, Manon-Jensen T, Whiteford JR, Couchman JR, (2009) Syndecan proteoglycan contributions to cytoskeletal organization and contractility. Scand J Med Sci Sports 19: 479-489.
5. Chakravarti R, Adams JC, (2006) Comparative genomics of the syndecans defines an ancestral genomic context associated with matrilins in vertebrates. BMC Genomics 7: 83.
6. Whiteford JR, Behrends V, Kirby H, Kusche-Gullberg M, Muramatsu T, et al. (2007) Syndecans promote integrin-mediated adhesion of mesenchymal cells in two distinct pathways. Exp Cell Res 313: 3902-3913.
7. Beauvais DM, Ell BJ, McWhorter AR, Rapraeger AC, (2009) Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor. J Exp Med 206: 691-705.
8. Xian X, Gopal S, Couchman JR, (2009) Syndecans as receptors and organizers of the extracellular matrix. Cell Tissue Res.
9. Endo K, Takino T, Miyamori H, Kinsen H, Yoshizaki T, et al. (2003) Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration. J Biol Chem 278: 40764-40770.
10. Subramanian SV, Fitzgerald ML, Bernfield M, (1997) Regulated shedding of syndecan-1 and-4 ectodomains by thrombin and growth factor receptor activation. J Biol Chem 272: 14713-14720.
11. Jalkanen M, Rapraeger A, Saunders S, Bernfield M, (1987) Cell surface proteoglycan of mouse mammary epithelial cells is shed by cleavage of its matrix-binding ectodomain from its membrane-associated domain. J Cell Biol 105: 3087-3096.
12. Wang Z, Gotte M, Bernfield M, Reizes O, (2005) Constitutive and accelerated shedding of murine syndecan-1 is mediated by cleavage of its core protein at a specific juxtamembrane site. Biochemistry 44: 12355-12361.
13. Asundi VK, Carey DJ, (1995) Self-association of N-syndecan (syndecan-3) core protein is mediated by a novel structural motif in the transmembrane domain and ectodomain flanking region. J Biol Chem 270: 26404-26410.
14. Alexopoulou AN, Multhaupt HA, Couchman JR, (2007) Syndecans in wound healing, inflammation and vascular biology. Int J Biochem Cell Biol 39: 505-528.
15. Woods A, Couchman JR, (2001) Syndecan-4 and focal adhesion function. Curr Opin Cell Biol 13: 578-583.
16. Zimmermann P, Zhang Z, Degeest G, Mortier E, Leenaerts I, et al. (2005) Syndecan recycling [corrected] is controlled by syntenin-PIP2 interaction and Arf6. Dev Cell 9: 377-388.
17. Chakravarti R, Sapountzi V, Adams JC, (2005) Functional role of syndecan-1 cytoplasmic V region in lamellipodial spreading, actin bundling, and cell migration. Mol Biol Cell 16: 3678-3691.
18. Brockstedt U, Dobra K, Nurminen M, Hjerpe A, (2002) Immunoreactivity to cell surface syndecans in cytoplasm and nucleus: tubulin-dependent rearrangements. Exp Cell Res 274: 235-245.
19. Chen L, Sanderson RD, (2009) Heparanase regulates levels of syndecan-1 in the nucleus. PLoS One 4: e4947.
20. Nikolova V, Koo CY, Ibrahim SA, Wang Z, Spillmann D, et al. (2009) Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression. Carcinogenesis 30: 397-407.
21. Zong F, Fthenou E, Wolmer N, Hollosi P, Kovalszky I, et al. (2009) Syndecan-1 and FGF-2, but not FGF receptor-1, share a common transport route and co-localize with heparanase in the nuclei of mesenchymal tumor cells. PLoS One 4: e7346.
22. Zong F, Fthenou E, Castro J, Peterfia B, Kovalszky I, et al. (2009) Effect of syndecan-1 overexpression on mesenchymal tumour cell proliferation with focus on different functional domains. Cell Prolif.
23. Stanley MJ, Liebersbach BF, Liu W, Anhalt DJ, Sanderson RD, (1995) Heparan sulfate-mediated cell aggregation. Syndecans-1 and-4 mediate intercellular adhesion following their transfection into human B lymphoid cells. J Biol Chem 270: 5077-5083.
24. Liu W, Litwack ED, Stanley MJ, Langford JK, Lander AD, et al. (1998) Heparan sulfate proteoglycans as adhesive and anti-invasive molecules. Syndecans and glypican have distinct functions. J Biol Chem 273: 22825-22832.
25. Burbach BJ, Ji Y, Rapraeger AC, (2004) Syndecan-1 ectodomain regulates matrix-dependent signaling in human breast carcinoma cells. Exp Cell Res 300: 234-247.
26. Beauvais DM, Burbach BJ, Rapraeger AC, (2004) The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells. J Cell Biol 167: 171-181.
27. Langford JK, Yang Y, Kieber-Emmons T, Sanderson RD, (2005) Identification of an invasion regulatory domain within the core protein of syndecan-1. J Biol Chem 280: 3467-3473.
28. Beauvais DM, Rapraeger AC, (2003) Syndecan-1-mediated cell spreading requires signaling by alphavbeta3 integrins in human breast carcinoma cells. Exp Cell Res 286: 219-232.
29. Morgan MR, Humphries MJ, Bass MD, (2007) Synergistic control of cell adhesion by integrins and syndecans. Nat Rev Mol Cell Biol 8: 957-969.
30. Bass MD, Humphries MJ, (2002) Cytoplasmic interactions of syndecan-4 orchestrate adhesion receptor and growth factor receptor signalling. Biochem J 368: 1-15.
31. Carter SB, (1965) Principles of cell motility: the direction of cell movement and cancer invasion. Nature 208: 1183-1187.
32. Lo CM, Wang HB, Dembo M, Wang YL, (2000) Cell movement is guided by the rigidity of the substrate. Biophys J 79: 144-152.
33. Petrie RJ, Doyle AD, Yamada KM, (2009) Random versus directionally persistent cell migration. Nat Rev Mol Cell Biol 10: 538-549.
34. Bailly M, Yan L, Whitesides GM, Condeelis JS, Segall JE, (1998) Regulation of protrusion shape and adhesion to the substratum during chemotactic responses of mammalian carcinoma cells. Exp Cell Res 241: 285-299.
35. Harms BD, Bassi GM, Horwitz AR, Lauffenburger DA, (2005) Directional persistence of EGF-induced cell migration is associated with stabilization of lamellipodial protrusions. Biophys J 88: 1479-1488.
36. Lee JH, Park H, Chung H, Choi S, Kim Y, et al. (2009) Syndecan-2 regulates the migratory potential of melanoma cells. J Biol Chem 284: 27167-27175.
37. Wilcox-Adelman SA, Denhez F, Iwabuchi T, Saoncella S, Calautti E, et al. (2002) Syndecan-4: dispensable or indispensable? Glycoconj J 19: 305-313.
38. Cattaruzza S, Perris R, (2005) Proteoglycan control of cell movement during wound healing and cancer spreading. Matrix Biol 24: 400-417.
39. Chalkiadaki G, Nikitovic D, Berdiaki A, Sifaki M, Krasagakis K, et al. (2009) Fibroblast growth factor-2 modulates melanoma adhesion and migration through a syndecan-4-dependent mechanism. Int J Biochem Cell Biol 41: 1323-1331.
40. Kirn-Safran C, Farach-Carson MC, Carson DD, (2009) Multifunctionality of extracellular and cell surface heparan sulfate proteoglycans. Cell Mol Life Sci 66: 3421-3434.
41. Lee YG, Macoska JA, Korenchuk S, Pienta KJ, (2002) MIM, a potential metastasis suppressor gene in bladder cancer. Neoplasia 4: 291-294.
42. Ma S, Guan XY, Lee TK, Chan KW, (2007) Clinicopathological significance of missing in metastasis B expression in hepatocellular carcinoma. Hum Pathol 38: 1201-1206.
43. Liu K, Wang G, Ding H, Chen Y, Yu G, et al. (2010) Downregulation of metastasis suppressor 1(MTSS1) is associated with nodal metastasis and poor outcome in Chinese patients with gastric cancer. BMC Cancer 10: 428.
44. Parr C, Jiang WG, (2009) Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer. Eur J Cancer 45: 1673-1683.
45. Boles KS, Mathew PA, (2001) Molecular cloning of CS1, a novel human natural killer cell receptor belonging to the CD2 subset of the immunoglobulin superfamily. Immunogenetics 52: 302-307.
46. Bouchon A, Cella M, Grierson HL, Cohen JI, Colonna M, (2001) Activation of NK cell-mediated cytotoxicity by a SAP-independent receptor of the CD2 family. J Immunol 167: 5517-5521.
47. Kumaresan PR, Lai WC, Chuang SS, Bennett M, Mathew PA, (2002) CS1, a novel member of the CD2 family, is homophilic and regulates NK cell function. Mol Immunol 39: 1-8.
48. Lee JK, Mathew SO, Vaidya SV, Kumaresan PR, Mathew PA, (2007) CS1 (CRACC, CD319) induces proliferation and autocrine cytokine expression on human B lymphocytes. J Immunol 179: 4672-4678.
49. Cannons JL, Tangye SG, Schwartzberg PL, (2011) SLAM family receptors and SAP adaptors in immunity. Annu Rev Immunol 29: 665-705.
50. Izawa I, Nishizawa M, Ohtakara K, Inagaki M, (2002) Densin-180 interacts with delta-catenin/neural plakophilin-related armadillo repeat protein at synapses. J Biol Chem 277: 5345-5350.
51. Ivanova AV, Goparaju CM, Ivanov SV, Nonaka D, Cruz C, et al. (2009) Protumorigenic role of HAPLN1 and its IgV domain in malignant pleural mesothelioma. Clin Cancer Res 15: 2602-2611.
52. Peterfia B, Hollosi P, Szilak L, Timar F, Paku S, et al. (2006) [Role of syndecan-1 proteoglycan in the invasiveness of HT-1080 fibrosarcoma]. Magy Onkol 50: 115-120.
53. Klominek J, Robert K-H, Hjerpe A, Wickström B, Gahrton G, (1989) Serum- dependent growth patterns of two, newly established human mesothelioma cell lines. Cancer Res 49: 6118-6122.
54. Thurzo V, Popovic M, Matoska J, Blasko M, Grofova M, et al. (1976) Human neoplastic cells in tissue culture: two established cell lines derived from giant cell tumor and fibrosarcoma. Neoplasma 23: 577-587.
55. Dobra K, Andang M, Syrokou A, Karamanos NK, Hjerpe A, (2000) Differentiation of mesothelioma cells is influenced by the expression of proteoglycans. Exp Cell Res 258: 12-22.
56. Hulsen T, de Vlieg J, Alkema W, (2008) BioVenn- a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. BMC Genomics 9: 488.